Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
GENNEX LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 153.7027.91-4.2368.10-12.63

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 153.70 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10
Mar2020-12.63

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1
Positive
Mar2020 -12.63 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹347.6 Cr -12.9% 12.4% -26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,170.0 Cr -2.6% -0.9% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -1.3% 0.8% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr 0.2% -3.5% -5.8% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-12.9%

12.4%

-26.7%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses